ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Proposed DRG Regulations Would Limit Exemptions To Fox Chase, M.D. Anderson; In Effect Oct. 1

September 9, 1983

NCI Programs: Colorectal Cancer Progress Review Group To Assess Research

October 1, 1999

House Approves $619M Increase For NIH.

February 2, 2007

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013

Michael Grever To Head DTP; Chabner’s Deputy Is Kaufman; Radiation Program To Be Split

April 5, 1991

Black-White Disparity Seen In End Of Life Treatment

November 27, 2009